Humana Inc (NYSE: HUM) has a higher price-to-earnings ratio of 26.33x compared to its average ratio. HUM has 36-month beta value of 0.57. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 3 as “overweight,” 17 as “hold,” and 0 as “sell.”
The public float for HUM is 120.14M, and currently, short sellers hold a 4.65% ratio of that float. The average trading volume of HUM on January 23, 2025 was 1.75M shares.
HUM) stock’s latest price update
The stock of Humana Inc (NYSE: HUM) has increased by 4.37 when compared to last closing price of 284.92.Despite this, the company has seen a gain of 6.40% in its stock price over the last five trading days. prnewswire.com reported 2025-01-21 that Talicia is now covered by Humana’s Part D Plan, providing access to Talicia for H. pylori therapy to more than eight million additional Medicare lives, without requiring prior therapeutic steps or authorization The recently updated American College of Gastroenterology (ACG) Clinical Guideline lists Talicia as a first-line option for treatment of H.
HUM’s Market Performance
Humana Inc (HUM) has seen a 6.40% rise in stock performance for the week, with a 26.13% gain in the past month and a 14.13% surge in the past quarter. The volatility ratio for the week is 3.24%, and the volatility levels for the past 30 days are at 3.33% for HUM. The simple moving average for the past 20 days is 10.35% for HUM’s stock, with a -6.32% simple moving average for the past 200 days.
Analysts’ Opinion of HUM
Many brokerage firms have already submitted their reports for HUM stocks, with BofA Securities repeating the rating for HUM by listing it as a “Neutral.” The predicted price for HUM in the upcoming period, according to BofA Securities is $308 based on the research report published on November 06, 2024 of the previous year 2024.
Bernstein gave a rating of “Outperform” to HUM, setting the target price at $308 in the report published on October 08th of the previous year.
HUM Trading at 7.98% from the 50-Day Moving Average
After a stumble in the market that brought HUM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.79% of loss for the given period.
Volatility was left at 3.33%, however, over the last 30 days, the volatility rate increased by 3.24%, as shares surge +16.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.38% upper at present.
During the last 5 trading sessions, HUM rose by +3.35%, which changed the moving average for the period of 200-days by -7.75% in comparison to the 20-day moving average, which settled at $269.06. In addition, Humana Inc saw 17.21% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HUM starting from Huval Timothy S., who sale 3,703 shares at the price of $256.26 back on Dec 31 ’24. After this action, Huval Timothy S. now owns 8,181 shares of Humana Inc, valued at $948,925 using the latest closing price.
Huval Timothy S., the Officer of Humana Inc, proposed sale 3,703 shares at $253.42 during a trade that took place back on Dec 31 ’24, which means that Huval Timothy S. is holding shares at $938,433 based on the most recent closing price.
Stock Fundamentals for HUM
Current profitability levels for the company are sitting at:
- 0.02 for the present operating margin
- 0.88 for the gross margin
The net margin for Humana Inc stands at 0.01. The total capital return value is set at 0.08. Equity return is now at value 7.88, with 2.57 for asset returns.
Based on Humana Inc (HUM), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at -0.28. The debt to equity ratio resting at 0.74. The interest coverage ratio of the stock is 4.08.
Currently, EBITDA for the company is 4.93 billion with net debt to EBITDA at 2.1. When we switch over and look at the enterprise to sales, we see a ratio of 0.38. The receivables turnover for the company is 53.64for trailing twelve months and the total asset turnover is 2.3. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.76.
Conclusion
To put it simply, Humana Inc (HUM) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
